Company performance
Add to research
Current Price
as of May 23, 2025$125.05
P/E Ratio
30.12
Market Cap
$3.61B
Description
Add to research
Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.
Metrics
Add to research
Overview
- HQPittsburgh, PA
- SectorHealth Technology
- IndustryBiotechnology
- TickerKRYS
- Price$125.05-0.19%
Trading Information
- Market cap$3.61B
- Float85.86%
- Average Daily Volume (1m)407,169
- Average Daily Volume (3m)337,608
- EPS$4.31
Company
- Revenue$333.45M
- Rev growth (1yr)94.88%
- Net income$35.73M
- Gross margin92.45%
- EBITDA margin42.88%
- EBITDA$37.81M
- EV$4.78B
- EV/Revenue14.33
- P/E30.12
- P/S11.20
- P/B3.67
- Debt/Equity0.98
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account